
|Videos|December 10, 2014
Concerns Over Drug Interaction Alert Fatigue
Daniel C. Malone, RPh, PhD, FAMCP, defines drug interaction alert fatigue.
Advertisement
Daniel C. Malone, RPh, PhD, FAMCP, a professor of pharmacy at the University of Arizona College of Pharmacy, defines drug interaction alert fatigue.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
2
IRAKLIA Trial Shows Body Weight Doesn’t Alter Outcomes With On-Body Injector Isatuximab
3
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
4
Advancing Precision Oncology: Perspectives for Pharmacists on MRD Testing and Diagnostic Innovation
5

















































































































































































































